EGYP

COM:EGYPTOTSUKA

Egypt Otsuka Pharmaceuticals

  • Privately Held

Company Overview

Metric
Company NameEgypt Otsuka PharmaceuticalsOtsuka Holdings Co., Ltd.
Symbol4.58K
MSH IDCOM:EGYPTOTSUKACOM:OTSUKA
MarketPRIVATESTOCKS
SectorHealthcare & Health ServicesHealthcare
IndustryPharmaceuticalsDrug Manufacturers - General
CountryEGJP
Stage
Employee Count34.39K
Websiteegyptotsuka.comotsuka.com
LinkedIn
Founders

Market Metrics

Metric
Market Cap26.07B
Enterprise Value
Monthly Web Traffic46.07K
Web Traffic Growth1.45
Valuation
Raised Capital

Financial Performance

Metric
Revenue13.46B
Revenue (LTM)
Revenue (NTM)
Gross Profit9.39B
EBITDA2.60B
Operating Income1.95B
Net Income811.10M
EPS1.49
Diluted EPS1.49
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.71
Operating Profit Margin0.15
EBITDA Margin0.19
Net Profit Margin0.07
Return on Equity0.06
Return on Assets0.04
Return on Capital Employed0.11

Valuation Multiples

Metric
P/E Ratio16.87
P/B Ratio1.25
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio2.26
EV Multiple11.34

Operational Metrics

Metric
Days Sales Outstanding94.09
Days Payables Outstanding115.26
Days Inventory Outstanding169.37
Operating Cycle259.01
Cash Conversion Cycle136.71
Asset Turnover0.61

Cash Flow Metrics

Metric
Operating Cash Flow1.89B
Free Cash Flow1.12B
Cash Flow to Debt1.80
Operating Cash Flow/Sales0.14
Free Cash Flow Yield0.04

Balance Sheet Metrics

Metric
Cash & Equivalents3.42B
Accounts Receivable-212.10M
Inventory1.66B
Goodwill2.53B
Debt to Capitalization0.07
Debt to Assets0.05
Current Ratio2.14
Quick Ratio1.66

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue0.15
SG&A to Revenue0.40